Formic Acid

Formic Acid

SCHEMBL2161063

CC(CO)(CO)CO.O=C(O)C1CCCCC1.O=C(O)C1CCCCC1.O=CO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 1/20 0.37
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
LMNA P02545 3/20 0.34
BTK Q06187 1/20 0.34
PLG P00747 1/20 0.33
PLAT P00750 1/20 0.33
SLC6A1 P30531 2/20 0.32
TSHR P16473 2/20 0.32
SLC6A11 P48066 1/20 0.32
SLC6A13 Q9NSD5 1/20 0.32
APLNR P35414 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL2160511 0.98 SMN1; SMN2 (0.38) SMN1; SMN2HSD17B10CES2CES1LMNA
Formic Acid SCHEMBL2161528 0.95 BTK (0.38) SMN1; SMN2HSD17B10LMNABTKPLG
Cyclopropane Carboxylic Acid SCHEMBL2160660 0.91 LMNA (0.41) SMN1; SMN2LMNABTKPLGPLAT
Formic Acid SCHEMBL2161094 0.83 SMN1; SMN2 (0.33) SMN1; SMN2HSD17B10CES2CES1LMNA
SCHEMBL11401804 0.83 SMN1; SMN2 (0.42) SMN1; SMN2HSD17B10CES2CES1LMNA
Formic Acid SCHEMBL31335430 0.82 CES2 (0.50) SMN1; SMN2CES2CES1LMNAPLG
Formic Acid SCHEMBL27598762 0.82 CES2 (0.50) SMN1; SMN2CES2CES1LMNAPLG
SCHEMBL2847820 0.81 SMN1; SMN2 (0.46) SMN1; SMN2HSD17B10CES2CES1LMNA
Formic Acid SCHEMBL2160952 0.81 SMN1; SMN2 (0.34) SMN1; SMN2HSD17B10CES2CES1LMNA
Formic Acid SCHEMBL27763854 0.80 TSHR (0.46) SMN1; SMN2CES2CES1LMNAPLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985502-B2 Containing formic ester additive; cycling properties, electrical capacity, storage during charging UBE INDUSTRIES, LTD. (JP) 2011-07-26 US disclosed
EP-1729365-B1 NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING THE SAME UBE INDUSTRIES (JP) 2010-12-22 EP disclosed
US-20080241704-A1 Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same UBE INDUSTRIES, LTD (JP) 2008-10-02 US disclosed
EP-1729365-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME Ube Industries, Ltd. (JP) 2006-12-06 EP disclosed